Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

NCT03281954 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1550

Enrollment

NETWORK

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Placebo
DRUG: Atezolizumab

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]
[object Object]